Broadly, we have a number of concerns with New Fortress business model and its ability to earn durable returns that contribute to our no-moat rating. Currently, New Fortress terminals are in ...
Companies within the fields of biotechnology and pharmaceuticals work to develop medicines for the treatment of various diseases and medical conditions. Typically, companies in both industries tend to ...
There is a fortress atop a hill overseeing two rivers: One natural, the other a man-made canal. The first building made there was wooden, but by 1683, the Cossacks who had conquered Siberia has grown ...
We are initiating coverage on New Fortress Energy NFE with a $30 per share fair value estimate and a no-moat rating. Shares are about fairly valued currently; however, they tend to be volatile ...
NEW YORK and BORDENTOWN, N.J., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and ...
The average one-year price target for Fortress Biotech (NASDAQ:FBIO) has been revised to 45.90 / share. This is an increase of 489.01% from the prior estimate of 7.79 dated October 4, 2023. The price ...
I've always liked SilverStone chassis. Classy looks, good thermal performance, and, usually, excellent build quality put them very near the top of the wish-list. Trouble is, most SilverStone chassis ...
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Companies within the fields of biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback